Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart patch outsmart hidden heart risks after stroke?

NCT ID NCT04624646

Diagnosis Sponsor: Ewha Womans University Mokdong Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at better ways to find hidden atrial fibrillation (an irregular heartbeat) in people who have had a stroke. About 337 participants will use either a wearable patch for 72 hours or a handheld device three times a day to monitor their heart rhythm. The goal is to see which method catches more cases of atrial fibrillation, so doctors can prescribe blood thinners to prevent another stroke.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

337 people

The number who actually took part.

Started

Nov 2020

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newly diagnosed brain infarction * No history and diagnosis of atrial fibrillation at the time of admission * Rejected implantable loop recorder * Informed consent Exclusion Criteria: * Cannot use KardiaMobile system alone or with the help of others

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation brain infarction ischemic stroke transient ischemic attack

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation Ischemic stroke Transient ischemic attack

Contacts and locations

Locations

  • Daegu Catholic University Medical Center

    Daegu, South Korea

  • Ewha Womans University Mokdong Hospital

    Yangcheon, Seoul, 07985, South Korea

  • Ewha Womans University Seoul Hospital

    Gangseo, Seoul, 07985, South Korea

  • Gachon University Gil Hospital

    Incheon, 21565, South Korea

  • Hanyang University Seoul Hospital

    Seongdong, Seoul, 04763, South Korea

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • Kyung Hee University Hospital

    Seoul, 02447, South Korea

  • Yonsei University Health System, Severance Hospital

    Seoul, 06273, South Korea

  • Yonsei University Health System, Yongin Severance Hospital

    Yongin, Gyeonggi-do, 17046, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.